Clinical trials
Completed Phase 4 Epilepsy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
73 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 4 |
| 2004 | 1 |
| 2005 | 8 |
| 2006 | 8 |
| 2007 | 2 |
| 2008 | 6 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 73 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eisai Korea Inc. | 6 |
| UCB Pharma | 5 |
| GlaxoSmithKline | 3 |
| University of Cincinnati | 3 |
| Eisai Limited | 2 |
| Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 2 |
| Nasim Tabrizi | 2 |
| Novartis | 2 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
| University of Maryland, Baltimore | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsy | 73 |
| Seizures | 17 |
| Epilepsies, Partial | 8 |
| Nervous System Diseases | 5 |
| Anxiety Disorders | 3 |
| Attention Deficit Disorder with Hyperactivity | 2 |
| Brain Diseases | 2 |
| Brain Neoplasms | 2 |
| Headache | 2 |
| Learning Disabilities | 2 |
Trials
Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.